Data as of Dec 19
| +0.57 / +0.30%|
The 20 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 214.50, with a high estimate of 240.00 and a low estimate of 170.00. The median estimate represents a +13.17% increase from the last price of 189.53.
The current consensus among 22 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.